Pfizer Inc (NYSE:PFE)
| 40.45 BATS BZX Real-Time Price As of 10:14am ET |  +2.14 / +5.59%Today’s Change | 26.43 Today|||52-Week Range 40.49 | +8.91% Year-to-Date |
Latest PFE News | Press Releases
| What Should Investors Know About AstraZeneca's Coronavirus Vaccine? 9:52am / MotleyFool.com - Paid Partner Content | Is Novavax Stock a Buy? 6:33am / MotleyFool.com - Paid Partner Content |
| 3 Pharma Stocks With Dividends Above 4% to Buy Now 8:39am / MotleyFool.com - Paid Partner Content | Here's Why Johnson & Johnson Is Still in the Coronavirus Vaccine Race 6:30am / MotleyFool.com - Paid Partner Content |
| The 2 Best ETFs for Dividends 8:33am / MotleyFool.com - Paid Partner Content | 4 Reasons the Stock Market Could Crash in the Next 3 Months 6:06am / MotleyFool.com - Paid Partner Content |
| COVID-19 Vaccine Race Heats Up: Drugmarkers on Final Lap 8:05am / Zacks.com - Paid Partner Content | This COVID Vaccine Is Already Shipping 6:05am / MotleyFool.com - Paid Partner Content |
| Stellar November Paves the Way for a Solid December: 5 Picks 6:35am / Zacks.com - Paid Partner Content | Moderna's Coronavirus Vaccine to Be Reviewed by FDA Advisory Committee on Dec. 17 Nov 30 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 38.31 |
| Today’s open | 39.40 |
| Day’s range | 39.01 - 40.49 |
| Volume | 20,727,870 |
| Average volume (3 months) | 30,213,459 |
| Market cap | $207.0B |
Data as of 10:14am ET, 12/01/2020
Growth & Valuation
| Earnings growth (last year) | +53.85% |
| Earnings growth (this year) | +0.57% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | -3.54% |
| P/E ratio | 25.8 |
| Price/Sales | 4.30 |
| Price/Book | 3.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.95 | -1.05% |
| MRKMerck | +1.60 | +1.99% |
| ABBVAbbVie | +1.44 | +1.38% |
| BMYBristol-Myers Squibb | +0.91 | +1.46% |
Data as of 10:14am ET, 12/01/2020
Financials
| Next reporting date | February 2, 2021 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $51.8B |
| Annual profit (last year) | $16.3B |
| Net profit margin | 31.44% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
